Literature DB >> 19778015

Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Shanta Dhar1, Weston L Daniel, David A Giljohann, Chad A Mirkin, Stephen J Lippard.   

Abstract

Amine-functionalized polyvalent oligonucleotide gold nanoparticles (DNA-Au NPs) were derivatized with a cisplatin prodrug, and the resulting DNA-Au NP conjugates were used to internalize multiple platinum centers. A platinum(IV) complex, c,c,t-[Pt(NH(3))(2)Cl(2)(OH)(O(2)CCH(2)CH(2)CO(2)H)], was tethered to the surface of DNA-Au NPs through amide linkages. The platinum-tethered gold nanoparticles were taken into several cancer cells. The drop in intracellular pH facilitated reductive release of cisplatin from the prodrug, which then formed 1,2-d(GpG) intrastrand cross-links in the cell nuclei, as confirmed by an antibody specific for this adduct. The cytotoxicity of the platinum(IV) complex increases significantly in several cancer cell lines when the complex is attached to the surface of the DNA-Au NPs and in some instances exceeds that of cisplatin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778015      PMCID: PMC2761975          DOI: 10.1021/ja9071282

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  19 in total

1.  Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

Authors:  E R Jamieson; S J Lippard
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT).

Authors:  B Arunachalam; U T Phan; H J Geuze; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Synthesis and characterization of AP5346, a novel polymer-linked diaminocyclohexyl platinum chemotherapeutic agent.

Authors:  Paul Sood; K Bruce Thurmond; Jeremy E Jacob; Lynda K Waller; George O Silva; Donald R Stewart; David P Nowotnik
Journal:  Bioconjug Chem       Date:  2006 Sep-Oct       Impact factor: 4.774

4.  Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design.

Authors:  Rodney P Feazell; Nozomi Nakayama-Ratchford; Hongjie Dai; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2007-06-15       Impact factor: 15.419

5.  Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents.

Authors:  C M Giandomenico; M J Abrams; B A Murrer; J F Vollano; M I Rheinheimer; S B Wyer; G E Bossard; J D Higgins
Journal:  Inorg Chem       Date:  1995-03       Impact factor: 5.165

6.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles.

Authors:  David A Giljohann; Dwight S Seferos; Pinal C Patel; Jill E Millstone; Nathaniel L Rosi; Chad A Mirkin
Journal:  Nano Lett       Date:  2007-11-13       Impact factor: 11.189

7.  Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

Authors:  S W Thompson; L E Davis; M Kornfeld; R D Hilgers; J C Standefer
Journal:  Cancer       Date:  1984-10-01       Impact factor: 6.860

8.  High-dose cisplatin treatment: hearing loss and plasma concentrations.

Authors:  G Laurell; U Jungnelius
Journal:  Laryngoscope       Date:  1990-07       Impact factor: 3.325

9.  Nanoscale coordination polymers for platinum-based anticancer drug delivery.

Authors:  William J Rieter; Kimberly M Pott; Kathryn M L Taylor; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2008-08-08       Impact factor: 15.419

10.  Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.

Authors:  Bernd Liedert; Dick Pluim; Jan Schellens; Jürgen Thomale
Journal:  Nucleic Acids Res       Date:  2006-03-29       Impact factor: 16.971

View more
  106 in total

1.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors:  Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Biocompatible infinite-coordination-polymer nanoparticle-nucleic-acid conjugates for antisense gene regulation.

Authors:  Colin M Calabrese; Chad A Mirkin; Timothy J Merkel; William E Briley; Pratik S Randeria; Suguna P Narayan; Jessica L Rouge; David A Walker; Alexander W Scott
Journal:  Angew Chem Int Ed Engl       Date:  2014-11-13       Impact factor: 15.336

3.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

Authors:  Yu Cheng; Joseph D Meyers; Richard S Agnes; Tennyson L Doane; Malcolm E Kenney; Ann-Marie Broome; Clemens Burda; James P Basilion
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

4.  Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum.

Authors:  Jennifer S Park; Joseph M Kinsella; Danielle D Jandial; Stephen B Howell; Michael J Sailor
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

5.  Synthesis, characterization, and photophysical properties of three platinum(II) complexes bearing fluorescent analogues of the Di-2-pyridylmethane ligand.

Authors:  Justin J Wilson; Juliana Fedoce Lopes; Stephen J Lippard
Journal:  Inorg Chem       Date:  2010-06-07       Impact factor: 5.165

6.  Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.

Authors:  Pinal C Patel; David A Giljohann; Weston L Daniel; Dan Zheng; Andrew E Prigodich; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

7.  Nanoconjugation: A Materials Approach to Enhance Epidermal Growth Factor Induced Apoptosis.

Authors:  Linxi Wu; Xinwei Yu; Amin Feizpour; Björn M Reinhard
Journal:  Biomater Sci       Date:  2014-02-01       Impact factor: 6.843

Review 8.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

Review 9.  Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking.

Authors:  Xue Xue; Matthew D Hall; Qiang Zhang; Paul C Wang; Michael M Gottesman; Xing-Jie Liang
Journal:  ACS Nano       Date:  2013-12-10       Impact factor: 15.881

10.  Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.

Authors:  Xiang Ling; Xing Chen; Imogen A Riddell; Wei Tao; Junqing Wang; Geoffrey Hollett; Stephen J Lippard; Omid C Farokhzad; Jinjun Shi; Jun Wu
Journal:  Nano Lett       Date:  2018-06-19       Impact factor: 11.189

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.